We are live on ! Find out more
GHSI

Guardion Health Sciences, Inc. Common Stock

Delisted

GHSI was delisted on the 11th of October, 2024.

18 hedge funds and large institutions have $1.83M invested in Guardion Health Sciences, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more capital invested

Capital invested by funds: $944K → $1.83M (+$882K)

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

20% more funds holding

Funds holding: 1518 (+3)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
4
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change

GHSI Hedge Fund Activity: Q4 2020 in Review

18 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q4 2020, worth a combined $1.83M — up 93% from $944K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new GHSI positions and 4 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $48.8K. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $51K sold.

  • 18 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q4 2020, up from 15 in Q3 2020.
  • Funds reported $1.83M of Guardion Health Sciences, Inc. Common Stock stock for Q4 2020, up 93% quarter-over-quarter.
  • 7 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q4 2020 and 4 closed out, a net change of +3 holders.
  • The largest Guardion Health Sciences, Inc. Common Stock buyer in Q4 2020 was Vanguard Group, an estimated $48.8K added.
  • The largest Guardion Health Sciences, Inc. Common Stock seller in Q4 2020 was Cambridge Investment Research Advisors, an estimated $51K sold.

Based on aggregated 13F filings for Q4 2020.